Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIENTINE TETRAHYDROCHLORIDE Cause Off label use? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Off label use have been filed in association with TRIENTINE TETRAHYDROCHLORIDE (CUVRIOR). This represents 28.4% of all adverse event reports for TRIENTINE TETRAHYDROCHLORIDE.

38
Reports of Off label use with TRIENTINE TETRAHYDROCHLORIDE
28.4%
of all TRIENTINE TETRAHYDROCHLORIDE reports
1
Deaths
3
Hospitalizations

How Dangerous Is Off label use From TRIENTINE TETRAHYDROCHLORIDE?

Of the 38 reports, 1 (2.6%) resulted in death, 3 (7.9%) required hospitalization, and 1 (2.6%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIENTINE TETRAHYDROCHLORIDE. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does TRIENTINE TETRAHYDROCHLORIDE Cause?

Product dose omission issue (16) Nausea (9) Maternal exposure during pregnancy (6)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which TRIENTINE TETRAHYDROCHLORIDE Alternatives Have Lower Off label use Risk?

TRIENTINE TETRAHYDROCHLORIDE vs TRIFAROTENE TRIENTINE TETRAHYDROCHLORIDE vs TRIFLUOPERAZINE TRIENTINE TETRAHYDROCHLORIDE vs TRIFLURIDINE TRIENTINE TETRAHYDROCHLORIDE vs TRIHEPTANOIN TRIENTINE TETRAHYDROCHLORIDE vs TRIHEXYPHENIDYL

Related Pages

TRIENTINE TETRAHYDROCHLORIDE Full Profile All Off label use Reports All Drugs Causing Off label use TRIENTINE TETRAHYDROCHLORIDE Demographics